Ciprofloxacin as broad-spectrum empiric therapy: are fluoroquinolones still viable monotherapeutic agents compared with β-lactams: data from the MYSTIC Program (US)? - Jones,R.N.; Pfaller,M.A. (Diagn Microbiol Infect Dis, 2002)